Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ASG-5ME |
| Trade Name | |
| Synonyms | ASG5ME|ASG 5ME |
| Drug Descriptions |
ASG-5ME is an antibody-drug conjugate (ADC) comprising an anti-SLC44A4 antibody linked to MMAE, which delivers the cytotoxic agent to SLC44A4-expressing tumor cells, potentially resulting in increased tumor cell death and decreased tumor growth (PMID: 27550944, PMID: 30725389). |
| DrugClasses | |
| CAS Registry Number | 1607823-18-6 |
| NCIT ID | C92590 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ASG-5ME | ASG-5ME | 0 | 0 |
| ASG-5ME + Nab-paclitaxel | ASG-5ME Nab-paclitaxel | 0 | 0 |